The World Health Organization and the Africa Centres for Disease Control and Prevention on 5 June launched a joint continental Ebola response plan that aims to raise US$518 million over six months, an unusually unified bid to contain an outbreak against which the field’s hard-won countermeasures do not work.
The plan covers June to November 2026 and is anchored on the ongoing outbreak in Ituri Province in the Democratic Republic of the Congo. According to WHO, the money would “support African countries together with partners to prepare for, rapidly detect and respond to the outbreak,” spanning emergency coordination, surveillance, laboratory testing, infection prevention and control, clinical care, community engagement, research and logistics.
The harder problem sits in the virology. The outbreak is caused by the Bundibugyo species of Ebola — and, as WHO put it plainly, “there are no licensed vaccines or therapeutics specifically approved for the Bundibugyo species.” The licensed Ebola vaccines and monoclonal-antibody treatments that reshaped the 2018–2020 response were developed against the Zaire species; they are not approved for Bundibugyo. That leaves the classic public-health tools — case finding, isolation, safe care and community trust — carrying the response.
A continental, not national, footprint
The plan complements national response plans launched by the governments of the Democratic Republic of the Congo and Uganda, and says critical measures are being strengthened in 10 priority countries to enhance preparedness and ensure early detection and swift response. WHO did not name those 10 countries in the announcement.
“Ebola moves fast. Africa must move faster,” said Dr Jean Kaseya, Director-General of Africa CDC.
WHO Director-General Dr Tedros Adhanom Ghebreyesus framed the joint structure as the operative bet: “The only way to beat this outbreak is through close partnership, working together under the leadership of the affected countries.” Containment, he added, “depends on political commitment, sustained financing, and the trust and engagement of communities.”
The $518 million is a target to be raised, not money in hand. WHO’s announcement did not break out funds already secured against the gap, nor did it publish confirmed case or death counts for the Ituri outbreak — figures typically tracked through separate situation reports. For now, the headline is the architecture: two continental health bodies pooling a single appeal and a single plan against a strain for which no vaccine or treatment exists.